β2- but not β1-adrenoceptor activation modulates intracellular oxygen availability

Journal of Physiology

Volumn 588, Issue 16, 2010, Pages 2987-2998

  Li, Jun ^a,b   Yan, Biao ^a,b   Huo, Zhaoxia ^a,b   Liu, Ying ^a,b   Xu, Jiahong ^a   Sun, Yunfu ^c   Liu, Yi ^a,b   Liang, Dandan ^a,b   Peng, Luying ^a,b   Zhang, Youyi ^d   Zhou, Zhao Nian ^e   Shi, Jingyi ^f   Cui, Jianmin ^f   Chen, Yi Han ^a,b  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b TONGJI UNIVERSITY   (China)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d PEKING UNIVERSITY THIRD HOSPITAL   (China)

^e Chinese Academy of Sciences   (China)

^f WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GUANINE NUCLEOTIDE BINDING PROTEIN; LUCIFERASE; NITRIC OXIDE; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; PROTEIN KINASE; REACTIVE OXYGEN METABOLITE; ADENYLATE KINASE; ADRB1 PROTEIN, RAT; BETA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ENZYME INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; NOS3 PROTEIN, RAT; OXYGEN; RENILLA LUCIFERIN 2 MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL LINE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE ACTIVATION; GENE CONTROL; HEART MUSCLE CELL; NONHUMAN; OXYGEN CONCENTRATION; PRIORITY JOURNAL; RAT; CELL LEVEL; ENZYME ACTIVATION; ENZYME INHIBITION; NEWBORN; OXYGEN CONSUMPTION; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN HOMEOSTASIS; REGULATORY MECHANISM; RENILLA; SIGNAL TRANSDUCTION; ANIMAL; BIOSYNTHESIS; CELL STRAIN COS1; CERCOPITHECUS; CYTOSOL; DRUG ANTAGONISM; DRUG EFFECT; GENETIC TRANSFECTION; GENETICS; HEART MITOCHONDRION; HOMEOSTASIS; METABOLISM; SPRAGUE DAWLEY RAT; TIME;

ADENOSINE MONOPHOSPHATE; ADENOSINE TRIPHOSPHATE; ADRENERGIC BETA-1 RECEPTOR AGONISTS; ADRENERGIC BETA-2 RECEPTOR AGONISTS; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; ANIMALS, NEWBORN; CERCOPITHECUS AETHIOPS; COS CELLS; CYTOSOL; ENZYME INHIBITORS; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; HOMEOSTASIS; LUCIFERASES, RENILLA; MITOCHONDRIA, HEART; MYOCYTES, CARDIAC; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; OXYGEN; PROCOLLAGEN-PROLINE DIOXYGENASE; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; RECEPTORS, ADRENERGIC, BETA-1; RECEPTORS, ADRENERGIC, BETA-2; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSFECTION;

EID: 77955720593     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2010.190900     Document Type: Article

References (47)

1. Allen JA, Halverson-Tamboli RA, Rasenick MM. Lipid raft microdomains and neurotransmitter signaling. Nat Rev Neurosci 2006, 8:128-140.
2. Allen JA, Yu JZ, Dave RH, Bhatnagar A, Roth BL, Rasenick MM. Caveolin-1 and lipid microdomains regulate Gs trafficking and attenuate Gs/adenylyl cyclase signaling. Mol Pharmacol 2009, 76:1082-1093.
3. Danson EJF, Zhang YH, Sears CE, Edwards AR, Casadei B, Paterson DJ. Disruption of inhibitory G-proteins mediates a reduction in atrial β-adrenergic signaling by enhancing eNOS expression. Cardiovasc Res 2005, 67:613-623.
4. Dasgupta B, Milbrandt J. Resveratrol stimulates AMP kinase activity in neurons. Proc Natl Acad Sci U S A 2007, 104:7217-7222.
5. DiPilato LM, Zhang J. The role of membrane microdomains in shaping β2-adrenergic receptor-mediated cAMP dynamics. Mol Biosyst 2009, 5:832-837.
6. Drummond GB. Reporting ethical matters in The Journal of Physiology: standards and advice. J Physiol 2009, 587:713-719.
7. Dyck JRB, Lopaschuk GD. AMPK alterations in cardiac physiology and pathology: enemy or ally?. J Physiol 2006, 574:95-112.
8. Goldstein S, Russo A, Samuni A. Reactions of PTIO and carboxy-PTIO with ·NO, ·NO2, and O2-·. J Biol Chem 2003, 278:50949-50955.
9. Griffiths JR, Robinson SP. The OxyLite: a fibre-optic oxygen sensor. Brit J Radiol 1999, 72:627-630.
10. Hagen T, Taylor CT, Lam F, Moncada S. Redistribution of intracellular oxygen in hypoxia by nitric oxide: effect on HIF1α. Science 2003, 302:1975-1978.
11. Hardie DG. AMPK: a key regulator of energy balance in the single cell and the whole organism. Int J Obes 2008, 4:S7-S12.
12. Head BP, Patel HH, Roth DM, Murray F, Swaney JS, Niesman IR, Farquhar MG, Insel PA. Microtubules and actin microfilaments regulate lipid raft/caveolae localization of adenylyl cyclase signaling components. J Biol Chem 2006, 281:26391-26399.
13. Iaccarino G, Ciccarelli M, Sorriento D, Galasso G, Campanile A, Santulli G, Cipolletta E, Cerullo V, Cimini V, Altobelli GG, Piscione F, Priante O, Pastore L, Chiariello M, Salvatore F, Koch WJ, Trimarco B. Ischemic neoangiogenesis enhanced by β2-adrenergic receptor overexpression: a novel role for the endothelial adrenergic system. Circ Res 2005, 97:1182-1189.
14. Iaccarino G, Cipolletta E, Fiorillo A, Annecchiarico M, Ciccarelli M, Cimini V, Koch WJ, Trimarco B. β2-Adrenergic receptor gene delivery to the endothelium corrects impaired adrenergic vasorelaxation in hypertension. Circulation 2002, 106:349-355.
15. Insel PA. Adrenergic receptors - evolving concepts and clinical implications. N Engl J Med 1996, 334:580-585.
16. Johnson M. The β-adrenoceptor. Am J Respir Crit Care Med 1998, 158:S146-S153.
17. Jo SH, Leblais V, Wang PH, Crow MT, Xiao RP. Phosphatidylinositol 3-kinase functionally compartmentalizes the concurrent Gs signaling during β2-adrenergic stimulation. Circ Res 2002, 91:46-53.
18. Kim J, Yoon MY, Choi SL, Kang I, Kim SS, Kim YS, Choi YK, Ha J. Effects of stimulation of AMP-activated protein kinase on insulin-like growth factor 1- and epidermal growth factor-dependent extracellular signal-regulated kinase pathway. J Biol Chem 2001, 276:19102-19110.
19. Kuschel M, Zhou YY, Cheng H, Zhang SJ, Chen Y, Lakatta EG, Xiao RP. Gi protein-mediated functional compartmentalization of cardiac β2-adrenergic signaling. J Biol Chem 1999, 274:22048-22052.
20. Laursen JB, Somers M, Kurz S, McCann L, Warnholtz A, Freeman BA, Tarpey M, Fukai T, Harrison DG. Endothelial regulation of vasomotion in apoE-deficient mice: implications for interactions between peroxynitrite and tetrahydrobiopterin. Circulation 2001, 103:1282-1288.
21. Lefkowitz RJ, Rockman HA, Koch WJ. Catecholamines, cardiac β-adrenergic receptors, and heart failure. Circulation 2000, 101:1634-1637.
22. Loeffen J, Elpeleg O, Smeitink J, Smeets R, Stöckler-Ipsiroglu S, Mandel H, Sengers R, Trijbels F, van den Heuvel L. Mutations in the complex I NDUFS2 gene of patients with cardiomyopathy and encephalomyopathy. Ann Neurol 2001, 49:195-201.
23. Mansart A, Bollaert PE, Giummelly P, Capdeville-Atkinson C, Atkinson J. Effects of dexamethasone and L-canavanine on the intracellular calcium-contraction relation of the rat tail artery during septic shock. Am J Physiol Heart Circ Physiol 2006, 291:H1177-H1182.
24. Mieno S, Watanabe F, Sawa Y, Horimoto H. Gene transfer of β2 adrenergic receptor enhances cardioprotective effects of ischemic preconditioning in rat hearts after myocardial infarction. Interact Cardiovasc Thorac Surg 2005, 4:163-167.
25. Moncada S, Erusalimsky JD. Does nitric oxide modulate mitochondrial energy generation and apoptosis?. Nat Rev Mol Cell Biol 2002, 3:214-220.
26. Moniri NH, Daaka Y. Agonist-stimulated reactive oxygen species formation regulates 2-adrenergic receptor signal transduction. Biochem Pharmacol 2007, 74:64-73.
27. Oehme F, Jonghaus W, Narouz-Ott L, Huetter J, Flamme I. A nonradioactive 96-well plate assay for the detection of hypoxia-inducible factor prolyl hydroxylase activity. Anal Biochem 2004, 330:74-80.
28. Ostrom RS, Insel PA. The evolving role of lipid rafts and caveolae in G protein-coupled receptor signaling: implications for molecular pharmacology. Br J Pharmacol 2004, 143:235-245.
29. Procaccio V, de Sury R, Martinez P, Depetris D, Rabilloud T, Soularue P, Lunardi J, Issartel JP. Mapping to 1q23 of the human gene (NDUFS2) encoding the 49-kDa subunit of the mitochondrial respiratory Complex I and immunodetection of the mature protein in mitochondria. Mamm Genome 1998, 9:482-484.
30. Raymond J, Segre D. The effect of oxygen on biochemical networks and the evolution of complex life. Science 2006, 311:1764-1767.
31. Riby JE, Firestone GL, Bjeldanes LF. 3,3-Diindolylmethane reduces levels of HIF-1 and HIF-1 activity in hypoxic cultured human cancer cells. Biochem Pharmacol 2008, 75:1858-1867.
32. Rockman HA, Koch WJ, Lefkowitz RJ. Seven-transmembrane-spanning receptors and heart function. Nature 2002, 415:206-212.
33. Rolfe DF, Brown GC. Cellular energy utilization and molecular origin of standard metabolic rate in mammals. Physiol Rev 1997, 77:731-758.
34. Rybin VO, Xu X, Lisanti MP, Steinberg SF. Differential targeting of β-adrenergic receptor subtypes and adenylyl cyclase to cardiomyocyte caveolae. A mechanism to functionally regulate the cAMP signaling pathway. J Biol Chem 2000, 275:41447-41457.
35. Salpeter SR, Ormiston TM, Salpeter EE. Cardiovascular effects of β-agonists in patients with asthma and COPD. Chest 2004, 125:2309-2321.
36. Seddon MD, Chowienczyk PJ, Brett SE, Casadei B, Shah AM. Neuronal nitric oxide synthase regulates basal microvascular tone in humans in vivo. Circulation 2008, 117:1991-1996.
37. Semenza GL. Life with oxygen. Science 2007a, 318:62-64.
38. Semenza GL. Oxygen-dependent regulation of mitochondrial respiration by hypoxia-inducible factor 1. Biochem J 2007b, 405:1-10.
39. Stadtman ER. Protein oxidation and aging. Free Radical Res 2006, 40:1250-1258.
40. Taylor CT. Mitochondria, oxygen sensing, and the regulation of HIF-2α. Focus on " Induction of HIF-2α is dependent on mitochondrial O2 consumption in an O2-sensitive adrenomedullary chromaffin cell line" Am J Physiol Cell Physiol 2008a, 294:C1300-C1302.
41. Taylor CT. Mitochondria and cellular oxygen sensing in the HIF pathway. Biochem J 2008b, 409:19-26.
42. Tong H, Bernstein D, Murphy E, Steenbergen C. The role of β-adrenergic receptor signaling in cardioprotection. FASEB J 2005, 19:983-985.
43. Towler MC, Hardie DG. AMP-activated protein kinase in metabolic control and insulin signaling. Circ Res 2007, 100:328-341.
44. Ushio-Fukai M. Localizing NADPH oxidase-derived ROS. Sci STKE 2006, 22:re8.
45. Waterhouse NJ, Goldstein JC, Von Ahsen O, Schuler M, Newmeyer DD, Green DR. Cytochrome c maintains mitochondrial transmembrane potential and ATP generation after outer mitochondrial membrane permeabilization during the apoptotic process. J Cell Biol 2001, 153:319-328.
46. Xiang Y, Rybin VO, Steinberg SF, Kobilka B. Caveolar localization dictates physiologic signaling of β2-adrenoceptors in neonatal cardiac myocytes. J Biol Chem 2002, 277:34280-34286.
47. Xie L, Xiao K, Whalen EJ, Forrester MT, Freeman RS, Fong G, Gygi SP, Lefkowitz RJ, Stamler JS. Oxygen-regulated β2-adrenergic receptor hydroxylation by EGLN3 and ubiquitylation by pVHL. Sci Signal 2009, 2:ra33.